Table 3.
Antibiotic Therapy by Class and Treatment Group
| Antibiotic Class | Saccharomyces boulardii Group (n = 246) | Placebo Group (n = 231) |
|---|---|---|
| β-lactam antibiotics | 201 (81.7%) | 181 (78.4%) |
| Tetracycline | 0 | 1 (0.4%) |
| Aminoglycosides | 1 (0.4%) | 0 |
| Macrolides | 52 (21.4%) | 55 (23.8%) |
| Lincosamides | 4 (1.6%) | 3 (1.3%) |
| Gyrase inhibitors | 40 (16.3%) | 41 (17.8%) |
| Sulfonamide/trimethoprim | 3 (1.2%) | 2 (0.9%) |
| Glycopeptide antibiotics | 0 | 0 |
| Polypeptide antibiotics | 0 | 0 |
| Nitroimidazole derivatives | 38 (15.5%) | 30 (13.0%) |
| Combination antibiotic therapy | ||
| 1 class only | 153 (62.2%) | 149 (64.5%) |
| 2 classes | 93 (37.8%) | 82 (35.5%) |